A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility

[1]  Chengzhan Zhu,et al.  Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma , 2023, Cancer Cell International.

[2]  Hiroshi Kobayashi,et al.  A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer , 2023, Cancer drug resistance.

[3]  Q. Xia,et al.  Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma , 2023, Cellular Oncology.

[4]  W. Zhang,et al.  Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma , 2023, Aging.

[5]  Y. Li,et al.  Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma , 2023, Heliyon.

[6]  Lizhi Lv,et al.  Upregulation of lncRNA PTOV1‐AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR‐505 , 2023, Journal of biochemical and molecular toxicology.

[7]  Qin Chen,et al.  Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies , 2023, Journal of Cancer Research and Clinical Oncology.

[8]  Kellen L. Olszewski,et al.  SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells , 2023, Nature communications.

[9]  A. Onogi,et al.  An R package for ensemble learning stacking , 2023, bioRxiv.

[10]  Feiyue Xing,et al.  Disulfidptosis: a new form of programmed cell death , 2023, Journal of Experimental & Clinical Cancer Research.

[11]  Lingyu Ma,et al.  Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients , 2023, Frontiers in Immunology.

[12]  Lin F. Yang,et al.  Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1 , 2023, Journal of Cancer Research and Clinical Oncology.

[13]  Haibo Wang,et al.  Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. , 2023, International immunopharmacology.

[14]  Beicheng Sun,et al.  The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination , 2023, Cell death discovery.

[15]  G. Hong,et al.  Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs , 2023, BMC Bioinformatics.

[16]  Chunting Zhou,et al.  Disulfidptosis: a new target for metabolic cancer therapy , 2023, Journal of Experimental & Clinical Cancer Research.

[17]  Zhixun Bai,et al.  Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer , 2023, Frontiers in Oncology.

[18]  Wei Ding,et al.  Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework , 2023, Frontiers in Endocrinology.

[19]  W. Yuan,et al.  Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma , 2023, Frontiers in Oncology.

[20]  Jianshuai Jiang,et al.  A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma. , 2023, Cancer biomarkers : section A of Disease markers.

[21]  Haikang Zeng,et al.  Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma. , 2023, Biotechnology & genetic engineering reviews.

[22]  Kellen L. Olszewski,et al.  Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis , 2023, Nature Cell Biology.

[23]  Minggen Hu,et al.  Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment , 2023, Frontiers in Immunology.

[24]  Yirun Li,et al.  Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma , 2023, Frontiers in Immunology.

[25]  Wenjing Chen,et al.  Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma , 2023, International journal of molecular sciences.

[26]  Bingbing Shen,et al.  A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma , 2022, Frontiers in Genetics.

[27]  J. Ferlay,et al.  Global burden of primary liver cancer in 2020 and predictions to 2040 , 2022, Journal of hepatology.

[28]  Yue Zhang,et al.  Long noncoding RNA LINC01124 activates hepatocellular carcinoma cell proliferation, migration, and invasion by absorbing microRNA-1247-5p and overexpressing FOXO3 , 2022, Oncology research.

[29]  Xiaojuan Ye,et al.  Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma , 2022, Frontiers in Molecular Biosciences.

[30]  C. Zhang,et al.  A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma , 2022, Frontiers in Immunology.

[31]  D. Vignali,et al.  Therapeutic targeting of regulatory T cells in cancer. , 2022, Trends in cancer.

[32]  B. Stockwell.  Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications , 2022, Cell.

[33]  Shichun Lu,et al.  Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature , 2022, Frontiers in Immunology.

[34]  Haizhou Qiu,et al.  The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma , 2022, Frontiers in Cell and Developmental Biology.

[35]  Xin Yang,et al.  Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma , 2022, Aging.

[36]  T. Golub,et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.

[37]  Ze Zhang,et al.  Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma , 2022, Frontiers in Cell and Developmental Biology.

[38]  Jia Liu,et al.  Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma , 2021, Frontiers in Cell and Developmental Biology.

[39]  Cheng Chen,et al.  Long non-coding RNA TMCC1-AS1 predicts poor prognosis and accelerates epithelial-mesenchymal transition in liver cancer , 2021, Oncology letters.

[40]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[41]  C. Peng,et al.  Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma. , 2021, Experimental and molecular pathology.

[42]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[43]  K. Evason,et al.  Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma , 2021, Hepatology.

[44]  Shihan Chen,et al.  Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma , 2021, Frontiers in Molecular Biosciences.

[45]  L. Zhuang,et al.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.

[46]  M. Xue,et al.  Long non-coding RNA MKLN1-AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR-654-3p, thereby promoting hepatoma-derived growth factor expression , 2020, International journal of molecular medicine.

[47]  Zhan Ye,et al.  Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols , 2020, RNA.

[48]  Christian M. Metallo,et al.  Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer , 2020, Nature Cell Biology.

[49]  Hashem B. El-Serag,et al.  Epidemiology of Hepatocellular Carcinoma , 2020, Hepatology.

[50]  Liliana Borges de Menezes,et al.  Tumor microenvironment components: Allies of cancer progression. , 2019, Pathology, research and practice.

[51]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[52]  G. Freeman,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[53]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[54]  Rohit Loomba,et al.  Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity , 2017, Nature.

[55]  Zhongheng Zhang,et al.  Drawing Nomograms with R: applications to categorical outcome and survival data. , 2017, Annals of translational medicine.

[56]  R. Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[57]  A. Chinnaiyan,et al.  The bright side of dark matter: lncRNAs in cancer. , 2016, The Journal of clinical investigation.

[58]  T. Pawlik,et al.  Hepatocellular carcinoma: From diagnosis to treatment. , 2016, Surgical oncology.

[59]  D. Kuang,et al.  Chemokine (C‐X‐C motif) receptor 3–positive B cells link interleukin‐17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma , 2015, Hepatology.

[60]  Guangchuang Yu,et al.  DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis , 2015, Bioinform..

[61]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[62]  Jeffrey T. Leek,et al.  Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction , 2014, Bioinform..

[63]  Roland Eils,et al.  circlize implements and enhances circular visualization in R , 2014, Bioinform..

[64]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[65]  Xuetao Cao,et al.  The origin and function of tumor-associated macrophages , 2014, Cellular and Molecular Immunology.

[66]  Jean-François Dartigues,et al.  Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risks , 2013, Statistics in medicine.

[67]  H. Baba,et al.  Identification of miR-30e* Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer , 2013, PloS one.

[68]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[69]  Trevor Hastie,et al.  Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent. , 2011, Journal of statistical software.

[70]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[71]  Uwe Ligges,et al.  Scatterplot3d - an R package for visualizing multivariate data , 2003 .

[72]  G. Gores,et al.  Hepatocellular carcinoma , 2016, Nature Reviews Disease Primers.